Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
A new real-world study reveals that advanced GLP-1 therapies, including semaglutide and tirzepatide, provide comparable glycemic control while offering superior weight benefits compared to metformin in adolescents newly diagnosed with type 2 diabetes
It really is a great all-in-one option
There are also ongoing trials exploring the role of GLP-1 agonists in addiction
Check your sleep habits carefully
Holly Wyattendocrinologist, obesity medicine physician, and author of Losing the Weight Loss Medsto explore what actually helps people keep weight off long-term, with or without medication
US$ 21.54
US$ 24.67
US$ 24.82
